Vito Michele Lauta

Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy

Franco Mandelli, Giuseppe Avvisati, Sergio Amadori et al. · New England Journal of Medicine · 1990 · 385 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.

Pier Luigi Zinzani, Enzo Pavone, Sergio Storti et al. · PubMed · 1997 · 163 citations

Medicine, Hematology, Oncology +16

Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.

Pier Luigi Zinzani, Sergio Storti, Alfonso Zaccaria et al. · PubMed · 1999 · 153 citations

Medicine, Geriatric Medicine, Oncology +10

Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma

Pier Luigi Zinzani, Alessandro Pulsoni, Alessio Perrotti et al. · Journal of Clinical Oncology · 2004 · 143 citations · Full text

Medicine, Hematology, Oncology +15

Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin’s Lymphoma: An Italian Multicenter Randomized Trial

Maurizio Martelli, Filíppo Gherlinzoni, Amalia De Renzo et al. · Journal of Clinical Oncology · 2003 · 130 citations

Medicine, Oncology, Cell Therapy +14